RxDoctor Payments Data

Nirav Shah, MD

Neurosurgery · Langhorne, PANPI 1477505329

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,643 of the $13,948 with a category attached, or 83.5%. 23 manufacturers reported payments, led by Si-bone, Inc. at 28.8% of the total. Reporting peaked in 2022 at $4,404 and has fallen 76.0% since, to $1,057 in 2025.

$13,948in general payments, 2019–2025

Across 152 payments — averaging $91.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$4K
  • Nevro Corp.$2K
  • Orthofix Medical, Inc.$1K
  • Electronic Waveform Lab, Inc.$1K
  • Boston Scientific$1K
  • Globus Medical$846
  • plus $3K from 17 others
$167,680in research payments, 2019–2025

Across 75 payments — averaging $2235.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$110K
  • Shire North American Group Inc$58K

What the payments were for

  • Consulting fees$1,46310%
  • Travel & lodging$8426%
  • Food & beverage$11,64383%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Si-bone, Inc.41$4,013
Nevro Corp.24$2,379
Orthofix Medical, Inc.2$1,468
Electronic Waveform Lab, Inc.8$1,039
Boston Scientific11$1,039
Globus Medical(2 entities)7$846
Stryker10$767
GSK19$551
Abbott7$510
Medtronic(2 entities)5$412
Intrinsic Therapeutics2$196
Spinal Simplicity, LLC2$181
Spacelabs Healthcare Inc1$138
Sanofi1$105
Baxter Healthcare1$69
Zimmer Biomet1$56
Dilon Technologies, Inc.1$50
AbbVie3$40
Sunovion Pharmaceuticals Inc.2$28
AstraZeneca1$17
Genentech USA, Inc.1$15
Mylan Specialty L.p.1$15
Johnson & Johnson1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurosurgery providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$30,270
Medicare patients
132
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurosurgery in Langhorne

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →